期刊文献+

USP2和CyclinD1蛋白在胃癌中的表达及其临床意义 被引量:7

Expression of USP2 and CyclinD1 in Gastric Carcinoma and Its Clinicopathologic Significance
原文传递
导出
摘要 [目的]分析胃癌中USP2蛋白和CyclinD1蛋白的表达及其临床意义。[方法 ]应用免疫组化方法检测胃癌组织和相应癌旁组织中USP2蛋白和Cyclin D1蛋白的表达情况,并与胃癌临床病理因素进行相关性分析。[结果]胃癌组织中USP2蛋白阳性表达率为63.3%(69/109),而癌旁组织中USP2阳性表达率为33.7%(34/101),两组比较有统计学差异(χ2=18.428,P<0.001)。胃癌组织中CyclinD1蛋白的阳性表达率为41.1%(49/111)。胃癌组织中USP2表达与CyclinD1表达高度相关(P=0.005);胃癌组织中Cyclin D1表达与远处转移和TNM分期呈正相关。[结论]胃癌组织中USP2异常表达可能通过其底物蛋白CyclinD1促进胃癌发展并影响患者的预后。 [Purposel To investigate the USP2 and CyclinD1 expression in gastric carcinoma and their clinicopathologic significance. [ Methods I The expressions of USP2,CyclinDl in gastric carcinoma tissue and paracancerous tissue were examined by immunohistoehemistry. The relationship of USP2,CyclinD1 proteins and clinicopathologic significance in gastric carcinoma was analyzed. [Results] The positive rate of USP2 protein expression in gastric carcinoma and paracancerous tissue was 63.3%(69/109) and 33.7%(33.7/101),respectively with significant difference (X2=18.428 ,P〈 0.001 ).The positive expression rate of CyclinDl protein in gastric carcinoma was 41.1% (49/111). There was significant positive correlation between expression of USP2 and CyclinDl in cancerous tissues(P=0.005). There was also positive correlation between expression of CyclinD1 in cancer tissues and distant metastasis and TNM stage. [Conclusion] Abnormal USP2 expression in gastric carcinoma may influence prognosis through CyelinD1 as a substrate.
机构地区 湖北省肿瘤医院
出处 《中国肿瘤》 CAS 2014年第3期257-260,共4页 China Cancer
基金 湖北省自然科学基金资助项目(2012FFB01703) 湖北省卫生厅科研资助项目(NX2011-14)
关键词 胃癌 USP2 CYCLIN D1 远处转移 TNM分期 gastric carcinoma USP2 CyclinD 1 distant metastasis TNM stage
  • 相关文献

参考文献3

二级参考文献21

  • 1[1]Hartwell LH,Kastan MB.Cell cycle control and cancer[J].Science,1994,266:1821.
  • 2[2]Motokura T,Bloom T,Kim HG,et al.A novel cyclin encoded by a bcli-linded candidate oncogene[J].Natrue,1991,350:512.
  • 3[3]Hunter T,Pines J.Cyclins and cancer Ⅱ:Cyclin D and CDK inhibators come of age[J].Cell,1994,79:573.
  • 4[4]Serrano M,Hannon GJ,Beach D.A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4[J].Nature,1993,366:704.
  • 5[5]Okamoto A,Demetrick DJ,Spillare EA,et al.Mutations and altered expression of p16INK4 in human cancer[J].Proc Natl Acad Sci USA,1994,91:11045.
  • 6[6]Matsushime H,Roussel MF,Ashmun RA,et al.Colonystimulating factor 1 Regulates novel cyclins during the G1 phase of the cell cycle[J].Cell,1991,65:701.
  • 7[7]Gansauge S,Gansauge F,Ramadani M,et al.Over expression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis[J].Cancer Res,1997,57:1634.
  • 8[8]Wang LD,Taoshi S,Zhou Q,et al.Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis[J].Int J Cancer,1994,59:514.
  • 9[9]Akama Y,Yasui W,Yokozaki H,et al.Frequent amplification of the cyclin E gene in human gastric carcinomas[J].Jpn J Cancer Res,1995,86:617.
  • 10[10]Sasaki H,Ishizuka T,Igaki H,et al.Mutation frenquency of the p16/CDKN2 gene and amplification of the cyclin E gene in human primary gastric carcinomas[J].Nippon-Rinsho,1996,54:1049.

共引文献22

同被引文献56

  • 1杨辉,李冀湘,崔向青,杨承,李连颖,刘俊玲,穆兰澄,苑景春,张冰.含黄药子制剂的临床应用及不良反应综述[J].临床误诊误治,2006,19(2):85-87. 被引量:4
  • 2SJ Moghaddam,EN Haghighi,S Samiee,N Shahid,AR Keramati,S Dadgar,MR Zali.Immunohistochemical analysis of p53,cyclinD1,RB1,c-fos and N-ras gene expression in hepatocellular carcinoma in Iran[J].World Journal of Gastroenterology,2007,13(4):588-593. 被引量:73
  • 3刘国魁,熊晨,宋学平.p16、cyclinD1在胃癌及癌前病变中表达与胃癌的关系[J].白求恩军医学院学报,2007,5(3):157-159. 被引量:4
  • 4Edgard Graner,Dan Tang,Sabrina Rossi,Antonella Baron,Toshiro Migita,Lisa J Weinstein,Mirna Lechpammer,Dieter Huesken,Johann Zimmermann,Sabina Signoretti,Massimo Loda.The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer[J].Cancer Cell.2004(3)
  • 5WANG Yian, YAO Ruisheng. Chemopreventive effect of a mixture of Chinese Herbs (antitumor B) on chemically induced oral carcinogenesis[J]. Mol Carcinog, 2013, 52(1): 49-56.
  • 6GAO Huiyuan. Antitumor-Promoting Constituents from Dioscorea bulbifera L. in JB6[J]. Biol Pharm Bull, 2002, 25(9): 1241-1243.
  • 7YANG Baohua, WANG Xintang. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry[J]. J Ethnopharmacol, 2013, 149(3): 810-815.
  • 8KUHN D M, BALKIS M. Uses and limitation s of the xTr assay in studies of Candida growth and metabolism [J]. J Clin Microbiol, 2003, all(l): 506-508.
  • 9HSIEH J L, WU Chaoliang. Hepatitis B virus X protein sensitizes hepatocellular lararcinoma ceils to cytolysis induced byE1 B- deleted adenovirus through the disruption of p53 function[ J]. Clin Cancer Res, 2003, 9(1): 338- 345.
  • 10WANG Junming. Antitumor activity of Dioscorea bulbifera L. rhizome in vivo[J]. Fitoterapia, 2012, 83(9): 388-394.

引证文献7

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部